Ensysce Biosciences, Inc. - ENSC

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$455K
QoQ value delta ($000)
-$370K (-44.85%)
Implied price effect (QoQ)
-61.41%
Shares
Total shares
502,620
QoQ shares delta
+150,921 (+42.91%)
Total shares held by funds (by quarter)

Market chart (ENSC)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q1 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
ADAGE CAPITAL PARTNERS GP, L.L.C. 137 149,711 0.0%
DRW Securities, LLC 90 98,481 0.0%
PERCEPTIVE ADVISORS LLC 79 86,666 0.0%
VANGUARD GROUP INC 33 36,708 0.0%
HRT FINANCIAL LP 22 24,491 0.0%
Financial Plan, Inc. 22 24,000 0.0%
GEODE CAPITAL MANAGEMENT, LLC 20 22,090 0.0%
TWO SIGMA SECURITIES, LLC 19 21,605 0.0%
Williams & Novak, LLC 16 17,850 0.01%
TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC 11 12,000 0.01%
Tower Research Capital LLC (TRC) 4 5,319 0.0%
FNY Investment Advisers, LLC 2 3,000 0.0%
BANK OF AMERICA CORP /DE/ 0 72 0.0%
JONES FINANCIAL COMPANIES LLLP 0 41 0.0%
UBS Group AG 0 100 0.0%
SBI Securities Co., Ltd. 0 421 0.0%
BlackRock, Inc. 0 65 0.0%